FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sandra Calarota

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Physiology

Immunologic Memory

Anatomy

Procedures

Highly Active Antiretroviral Therapy

Co-author Network

Publications

TOP 3
Paolo Biancheri; Sandra A Calarota; Gino R Corazza; Silvio Danese; Antonio Di Sabatino; Paolo Giuffrida; Alessandra Pasini; Laura Rovedatti; Stefania Vetrano; Francesca Vidali; Thomas T MacDonald
Effect of tumor necrosis factor-α blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease.
Sandra A Calarota; Antonella Chiesa; Giuditta Comolli; Annalisa De Silvestri; Pasquale Esposito; Piero Marone; Clara Migotto; Lorenzo Minoli; Carlo Pellegrini; Eleonora Sarchi; Carmine Tinelli; Paola Zelini; Fausto Baldanti
Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients.
Franco Lori; Renato Maserati; Aza Rakhmanova; Baev Denis; Pedro Cahn; Sandra A Calarota; Davide De Forni; Elly Katabira; Marco Testori; Michael R Stevens
VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sandra Calarota (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Paolo Biancheri; Sandra A Calarota; Gino R Corazza; Silvio Danese; Antonio Di Sabatino; Paolo Giuffrida; Alessandra Pasini; Laura Rovedatti; Stefania Vetrano; Francesca Vidali; Thomas T MacDonald
Effect of tumor necrosis factor-α blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease.
Inflammatory bowel diseases 2013;19(2):259-64.
2012: Sandra A Calarota; Antonella Chiesa; Giuditta Comolli; Annalisa De Silvestri; Pasquale Esposito; Piero Marone; Clara Migotto; Lorenzo Minoli; Carlo Pellegrini; Eleonora Sarchi; Carmine Tinelli; Paola Zelini; Fausto Baldanti
Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients.
Transplantation 2012;93(1):112-9.
2012: Franco Lori; Renato Maserati; Aza Rakhmanova; Baev Denis; Pedro Cahn; Sandra A Calarota; Davide De Forni; Elly Katabira; Marco Testori; Michael R Stevens
VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics.
PloS one 2012;7(10):e47485.
2012: Julianna Lisziewicz; Zsolt Lisziewicz; Brigitte Autran; Nyasha Bakare; Dénes Bánhegyi; Sandra A Calarota; Levente Molnár; J Szlávik; Enikő R Tőke; Eszter Ujhelyi; Franco Lori
Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals.
PloS one 2012;7(5):e35416.
2011: Antonio Di Sabatino; Sandra A Calarota; Francesca Vidali; Thomas T Macdonald; Gino R Corazza
Role of IL-15 in immune-mediated and infectious diseases.
Cytokine & growth factor reviews 2011;22(1):19-33.
2009: Stefania Paolucci; Andrea Foli; Roberto Gulminetti; Sandra A Calarota; Renato Maserati; Fausto Baldanti; Giuseppe Gerna
HIV-1 plasma variants encoding truncated reverse transcriptase (RT) in a patient with high RT-specific CD8+ memory T-cell response.
Current HIV research 2009;7(3):302-10.
2008: Sandra A Calarota; Anlan Dai; Jeffrey Trocio; David B Weiner; Franco Lori; Julianna Lisziewicz
IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine.
Vaccine 2008;26(40):5188-95.
2008: Sandra A Calarota; David Allen Hokey; Anlan Dai; Maria N Jure-Kunkel; Praveen Balimane; David B Weiner
Augmentation of SIV DNA vaccine-induced cellular immunity by targeting the 4-1BB costimulatory molecule.
Vaccine 2008;26(25):3121-34.
2008: Sandra A Calarota; Andrea Foli; Renato Maserati; Fausto Baldanti; Stefania Paolucci; Mary A Young; Christos M Tsoukas; Julianna Lisziewicz; Franco Lori
HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(9):5907-15.
2007: Julianna Lisziewicz; Sandra A Calarota; Franco Lori
The potential of topical DNA vaccines adjuvanted by cytokines.
Expert opinion on biological therapy 2007;7(10):1563-74.
2007: Sandra A Calarota; David B Weiner; Franco Lori; Julianna Lisziewicz
Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine.
Vaccine 2007;25(16):3070-4.
2007: Franco Lori; Sandra A Calarota; Julianna Lisziewicz
Nanochemistry-based immunotherapy for HIV-1.
Current medicinal chemistry 2007;14(18):1911-9.
2006: Franco Lori; David B Weiner; Sandra A Calarota; Laurene M Kelly; Julianna Lisziewicz
Cytokine-adjuvanted HIV-DNA vaccination strategies.
Springer seminars in immunopathology 2006;28(3):231-8.
2006: Miguel Otero; Sandra A Calarota; Anlan Dai; Anne S De Groot; Jean D Boyer; David B Weiner
Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy.
Vaccine 2006;24(21):4461-70.
2006: Sandra A Calarota; Miguel Otero; Tara M Robinson; Anlan Dai; Mark G Lewis; Jean D Boyer; David B Weiner
Independence of granzyme B secretion and interferon- gamma production during acute simian immunodeficiency virus infection.
The Journal of infectious diseases 2006;193(10):1441-50.
2005: Jeffrey A Encinas; edith janssen; David B Weiner; Sandra A Calarota; Daisy Nieto; Thomas Moll; Dennis J Carlo; Ronald B Moss
Anti-T-cell Ig and mucin domain-containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthma.
The Journal of allergy and clinical immunology 2005;116(6):1343-9.
2005: Jean D Boyer; Tara M Robinson; Michele A Kutzler; Rose Parkinson; Sandra A Calarota; Maninder K Sidhu; Karuppiah Muthumani; Mark Lewis; George Pavlakis; Barbara K Felber; David Weiner
SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques.
Journal of medical primatology 2005;34(5-6):262-70.
2004: Sandra A Calarota; David B Weiner
Approaches for the design and evaluation of HIV-1 DNA vaccines.
Expert review of vaccines 2004;3(4 Suppl):S135-49.
2004: Sandra A Calarota; David B Weiner
Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants.
Immunological reviews 2004;199():84-99.
2004: Miguel Otero; Sandra A Calarota; Barbara K Felber; Dominick J Laddy; George Pavlakis; Jean D Boyer; David B Weiner
Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model.
Vaccine 2004;22(13-14):1782-90.
2003: Joseph Kulkosky; Julie Sullivan; Yan Xu; Anne Malin-Markham; Miguel Otero; Sandra A Calarota; Jennifer Zielinski; Derek M Culnan; Roger J Pomerantz
Genotypic alteration of HAART-persistent HIV-1 reservoirs in vivo.
Virology 2003;314(2):617-29.
2003: Karuppiah Muthumani; Donghui Zhang; Nathanael S Dayes; Daniel S Hwang; Sandra A Calarota; Andrew Y Choo; Jean D Boyer; David B Weiner
Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo.
Virology 2003;314(1):134-46.
2003: Pierre Cordelier; Sandra A Calarota; Roger J Pomerantz; Jiang Xiaoshan; David S Strayer
Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2003;23(9):477-88.
2003: Sandra A Calarota; Miguel Otero; Keith Hermanstyne; Keith Hermanstayne; Mark Lewis; margherita rosati; Barbara K Felber; George Pavlakis; Jean D Boyer; David B Weiner
Use of interleukin 15 to enhance interferon-gamma production by antigen-specific stimulated lymphocytes from rhesus macaques.
Journal of immunological methods 2003;279(1-2):55-67.
2003: Pierre Cordelier; Elisabeth J Van Bockstaele; Sandra A Calarota; David S Strayer
Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(6):801-10.
2003: Sandra A Calarota; David B Weiner
Present status of human HIV vaccine development.
AIDS (London, England) 2003;17 Suppl 4():S73-84.
2002: Joseph Kulkosky; Giuseppe Nunnari; Miguel Otero; Sandra A Calarota; Geethanjali Dornadula; Hui Zhang; Anne Malin; Julie Sullivan; Yan Xu; Joseph DeSimone; Timothy Babinchak; John Stern; Winston Cavert; Ashley Haase; Roger J Pomerantz
Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy.
The Journal of infectious diseases 2002;186(10):1403-11.
2002: Pierre Cordelier; Sandra A Calarota; David S Strayer
Trans-activated interferon-alpha2 delivered to T cells by SV40 inhibits early stages in the HIV-1 replicative cycle.
Journal of hematotherapy & stem cell research 2002;11(5):817-28.
2002: David S Strayer; Francisco Branco; Mark A Zern; Priscilla Yam; Sandra A Calarota; Carmen N Nichols; John A Zaia; John Rossi; Haiting Li; Bhupesh Parashar; Siddhartha Ghosh; Jayanta Roy-Chowdhury
Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(2):227-37.